Clinical Trial: Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Observational
Official Title: Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
Brief Summary: The purpose of this study is to develop a new and very rapid diagnostic test for identifying a certain type of bacteria called Enterobacteriaceae in blood. Rapid identification of bacteria will assist in decreasing the use of antibiotics and help more patients survive bad bacterial infections of the blood.
Detailed Summary:
Sponsor: Denver Health and Hospital Authority
Current Primary Outcome:
- Accuracy of bacteria identification by the Accelerate ID/AST system compared to conventional microbiological methods of gram negative bacilli. [ Time Frame: 3 hours ]
- Accuracy of carbapenem susceptibility testing by the Accelerate ID/AST system compared to conventional microbiological methods of gram negative bacilli. [ Time Frame: 3 hours ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Denver Health and Hospital Authority
Dates:
Date Received: June 23, 2015
Date Started: July 2015
Date Completion: August 2019
Last Updated: June 1, 2016
Last Verified: June 2016
